Core set of unfavorable events of proximal humerus fracture treatment defined by an international Delphi consensus process.
Laurent Audigé, Stig Brorson, Holger Durchholz...
https://pubmed.ncbi.nlm.nih.gov/34847888/Actively Recruiting
Led by Zealand University Hospital · Updated on 2025-09-18
60
Participants Needed
2
Research Sites
52 weeks
Total Duration
This research aims to determine whether surgery leads to better functional outcomes than non-surgical treatment in patients aged 50 to 65 with displaced proximal humerus fractures. The study focuses on comparing osteosynthesis using either plate or intramedullary nail fixation to non-surgical care, while also examining factors like fracture type, osteoporosis status, and clinical frailty in this age group. Current knowledge mainly comes from older populations, so this trial fills an important gap for younger adults. Participants will be randomly assigned to receive either surgical treatment with osteosynthesis or non-surgical management. The surgical group will have follow-up visits at 2, 12, and 24 weeks with clinical and radiological assessments, while the non-surgical group will have visits at 6, 12, and 24 weeks. Both groups are referred to rehabilitation services. Surgical patients use a sling post-operation, while non-surgical patients may be offered an optional sling for comfort. During the study, participants will complete questionnaires including the Oxford Shoulder Score and EQ-5D-3L at 6 months, 12 months, and 24 months to assess function and quality of life. Researchers will monitor adverse events, any need for additional surgery, and rehabilitation adherence. The primary outcome is the Oxford Shoulder Score at 12 months, with additional evaluations at 6 and 24 months. Safety and treatment failures will also be tracked throughout the two-year follow-up.
CONDITIONS
Surgical Versus Non-surgical Treatment of Displaced Proximal Humerus Fracture in Adults Aged 50 to 65 Years
L
Line Løjbert Houkjær, M.D., ph.d.-student
S
Stig Brorson, Prof.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Zealand University Hospital
Lead Sponsor
Tampere University Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - Immediate post-surgery period
Participants assigned to the surgical group will undergo osteosynthesis and receive a sling and swathe immediately after surgery. From the first postoperative day, only the sling is used.
No specific visits during immediate post-operative care
Duration - Up to 24 weeks post-injury
Participants receive either surgical treatment with osteosynthesis or non-surgical treatment with optional sling use for comfort. Both groups are referred to rehabilitation in the municipalities.
Surgical group: 3 outpatient visits at 2, 12, and 24 weeks post-surgery; Non-surgical group: 3 visits at 2 weeks (10-14 days), 6 weeks, and 24 weeks post-injury
Duration - Up to 24 months
Participants are monitored with clinical and radiological assessments, including x-rays before every visit. Outcome measures such as shoulder function and quality of life are collected at 6, 12, and 24 months.
Visits at 6, 12, and 24 months for outcome assessments
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Laurent Audigé, Stig Brorson, Holger Durchholz...
https://pubmed.ncbi.nlm.nih.gov/34847888/Line Houkjær, Antti P Launonen, Bakir O Sumrein...
https://pubmed.ncbi.nlm.nih.gov/41466383/N Alispahic, S Brorson, C Bahrs...
https://pubmed.ncbi.nlm.nih.gov/32456631/Stig Brorson, Nikola Alispahic, Christian Bahrs...
https://pubmed.ncbi.nlm.nih.gov/30797232/Helen Hg Handoll, Joanne Elliott, Theis M Thillemann...
https://pubmed.ncbi.nlm.nih.gov/35727196/Zealand University Hospital
Lead Sponsor
Tampere University Hospital
Collaborating Sponsor